Core Viewpoint - The company, Fujian Aonong Biological Technology Group Co., Ltd., forecasts a significant decline in net profit for the year 2025, estimating a profit of between 90 million to 135 million yuan, which represents a decrease of 76.70% to 84.47% compared to the previous year [2][4]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. - The estimated net profit attributable to shareholders is projected to be between 90 million to 135 million yuan, a decrease of 44.43 million to 48.93 million yuan from the previous year [4]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between -450 million to -400 million yuan, indicating a reduction in losses of 75.25 million to 80.25 million yuan compared to the previous year [4]. Group 2: Previous Year’s Performance - In the previous year, the total profit was 84.49 million yuan, with a net profit attributable to shareholders of 579.35 million yuan [6]. - The net profit after deducting non-recurring gains and losses was -1.202 billion yuan [6]. - The earnings per share for the previous year were 0.67 yuan [7]. Group 3: Reasons for Performance Changes - The company has undergone bankruptcy restructuring, significantly reducing debt and interest expenses, while also improving production performance in its main business areas such as pig farming, feed, and slaughtering [8]. - The current year marks the first year post-restructuring, with some assets still not operational, leading to depreciation and amortization costs of approximately 80 million yuan [8]. - The company has recognized losses related to bad debt provisions and asset impairments amounting to about 200 million yuan [9]. - The benefits from debt restructuring have significantly decreased compared to 2024 [10]. Group 4: Future Strategy - The company aims to optimize its asset-liability structure and will focus on strategies such as enhancing feed production, optimizing pig farming, and developing food products [11]. - The company plans to control costs, enhance industry chain collaboration, and upgrade digitally while expanding into high-value food products and establishing regional fresh food brands [11].
福建傲农生物科技集团股份有限公司2025年年度业绩预告